
======================================================================
  PHARMA AGENTIC AI - GOLDEN TASK VALIDATION
  2025-12-11 15:57:36
======================================================================

======================================================================
  Golden Task 1: Whitespace Analysis
======================================================================
Γ¥î FAIL: IQVIA finds respiratory whitespace opportunities
   Result preview: **Whitespace Opportunities in Respiratory (India):**

- **Omalizumab** (Severe Asthma)
  Market: $65.0M | CAGR: 22.0% | Competition: Low | Patient Burden: High
- **Pirfenidone** (Idiopathic Pulmonary ...
Γ£à PASS: Clinical Agent analyzes COPD competition density

======================================================================
  Golden Task 2: Repurposing Opportunities
======================================================================
Γ£à PASS: Clinical Agent finds Pembrolizumab repurposing opportunities
   Result preview: **Repurposing Opportunities for Pembrolizumab:**

- **Non-Small Cell Lung Cancer** (None)
  Phase: Phase III | Sponsor: Merck Sharp & Dohme
  Competition: Medium | Unmet Need: Medium
  **Repurposing P...
Γ£à PASS: Patent Agent checks Pembrolizumab IP landscape

======================================================================
  Golden Task 3: FTO Check
======================================================================
Γ£à PASS: Patent Agent confirms Sitagliptin patent expired (2022-11-24)
   Result preview: **Patent Expiry Analysis for Sitagliptin (US):**

Γ£à **GENERIC ENTRY POSSIBLE** - All patents expired

Expired Patents:
  - US7326708 (Composition of Matter): Expired 2022-11-24...

======================================================================
  Golden Task 4: Patient Voice Analysis
======================================================================
Γ£à PASS: Social Agent identifies Diabetes patient complaints
   Result preview: **Patient Voice Analysis for Diabetes:**

**Posts Analyzed:** 5
**Molecules Discussed:** Insulin, Semaglutide
**Average Sentiment:** -0.30 (Neutral)

**Top Complaint Themes:**
  - Side effects: 1 mentions (20%)
  - Cost: 1 mentions (20%)
  - Needle pain: 1 mentions (20%)
  - Storage issues: 1 mentio...
Γ£à PASS: Innovation opportunities identified from patient feedback

======================================================================
  Golden Task 5: War Game Simulation
======================================================================
Γ£à PASS: Competitor Agent simulates war game scenario
   Result preview: **War Game Simulation: Rivaroxaban**

**Your Proposed Strategy:** Launch generic in 2025


**Predicted Competitor Responses:**

**Bayer (Authorized Generic):**
  Likely Counter: May accelerate own launch timeline. Launch authorized generic to discourage other entrants.
  Probability: High | Impact: ...
Γ£à PASS: Competitor Agent provides counter-strategies

======================================================================
  Integration Test: Full Orchestration
======================================================================
Γ£à PASS: Intent classification correct: ['iqvia', 'patent', 'clinical']
   Γä╣∩╕Å  Full crew execution skipped (requires API calls)

======================================================================
  Report Generation Test
======================================================================
Γ£à PASS: PDF generation: A:\Projects\Pharma\reports\pharma_report_20251211_155746.pdf
Γ£à PASS: Excel generation: A:\Projects\Pharma\reports\report_20251211_155746.xlsx

======================================================================
  TEST SUMMARY
======================================================================
  Γ£à Task 1: Whitespace
  Γ£à Task 2: Repurposing
  Γ£à Task 3: FTO Check
  Γ£à Task 4: Patient Voice
  Γ£à Task 5: War Game
  Γ£à Integration Test
  Γ£à Report Generation

  Total: 7/7 passed (10.16s)
======================================================================
